A digital decision-support tool aligned with allergic rhinitis guidelines may aid in identifying opportunities to adjust ...
A topical JAK inhibitor delivered as a nasal spray may ease nasal and eye symptoms in adults with moderate-to-severe seasonal ...
Allergic rhinitis is often mistaken for a cold. Here’s how to tell the difference and why newer-generation antihistamines may ...
Allergic rhinitis and asthma are among the most common chronic diseases today, affecting hundreds of millions of people ...
Please provide your email address to receive an email when new articles are posted on . The study used an online QHSLab platform to collect patient data. Higher SNOT-22 scores were associated with ...
Polyrizon Ltd. ( PLRZ ), a development-stage biotech company, announced that it has completed contracting with all five U.S. clinical sites, advancing the NASARIX Allergy Blocker (PL-14) program into ...
Please provide your email address to receive an email when new articles are posted on . 45.2% of patients who had “nasal allergies” had chronic rhinosinusitis. Patients with CRS tended to be older ...
The pharmacologic agents most often prescribed for patients with AR include oral H 1-antihistamines, intranasal or intraocular H 1-antihistamines, intranasal corticosteroids, nasal decongestants, ...
The non-pharmacologic nasal mist uses hydroxypropyl methylcellulose to form a protective physical barrier in the nasal passages, trapping and blocking airborne allergens.
Hay fever, also known as seasonal allergic rhinitis, is an allergy-related inflammation of the nasal passages, throat and eye membrane (conjunctiva), caused by sensitivity to airborne pollens and ...
Raanana, Israel, Sept. 02, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative intranasal ...
African ancestry in Black children was significantly associated with higher risk for asthma, allergen-specific IgE sensitization, and reduced lung function.